Fish Oil

fatty acid

Fish oil is derived from the tissues of oily fish and serves as a concentrated source of omega-3 polyunsaturated fatty acids. These fatty acids, particularly EPA and DHA, are integral components of cell membranes and support various physiological processes. The active compounds, EPA and DHA, contribute to brain development and function, vision, and immune system regulation. By incorporating into phospholipids within cell membranes, they influence membrane fluidity and cell signaling pathways, which are important for maintaining cellular health. Supplements are frequently used to increase omega-3 intake for those who do not regularly consume oily fish. Fish oil is recognized for its anti-inflammatory properties and its role in supporting cardiovascular, neurological, and joint health.

Natural sources
SalmonMackerelTunaSardinesHerringCod liver

No public comparison lists found.

Optimal Dosage
Minimum1000 mg
Maximum3000 mg
Safety & Toxicity
Toxicity Threshold5000 mg
Toxicity EffectIncreased bleeding risk
5 safety notes
  • Individuals with bleeding disorders or those taking blood-thinning medications should use with caution and consult a healthcare professional.
  • High doses may increase the risk of bleeding.
  • May cause stomach upset, fishy aftertaste, or diarrhea.
  • Pregnant or nursing women, children, and individuals with medical conditions should consult a healthcare professional before use.
  • Some fish oil supplements may contain contaminants like mercury; choose reputable brands.
Goals
Anti-Inflammatory Support
Impact
Highest effect
Typical dose:1000–3000 mg
Fish oil is a foundational supplement for managing inflammation. Its components, EPA and DHA, are incorporated into cell membranes and enzymatically converted into specialized pro-resolving mediators (SPMs) that actively turn off the inflammatory process. This helps reduce chronic inflammation and supports cardiovascular and joint health.

Study evidence

68 studies

Fish oil can lower some inflammatory markers, particularly in people with certain health conditions, but results vary substantially. These changes do not consistently translate into symptom relief, and research in healthy people often finds little or no anti-inflammatory benefit.

View goal
Cardiovascular Support
Impact
Highest effect
Typical dose:500–2000 EPA+DHA mg
Rich in the Omega-3 fatty acids EPA and DHA, which are integral to cell membranes throughout the body. They have extensive clinical evidence for improving lipid profiles (especially triglycerides), reducing systemic inflammation, and supporting endothelial function, which is critical for blood vessel health.

Study evidence

185 studies

Fish Oil reliably lowers elevated triglycerides and may modestly improve some cardiovascular outcomes, but broad prevention benefits are inconsistent. Effects depend on the population and formulation; some studies also report higher LDL cholesterol or an association with atrial fibrillation.

View goal
General Health
Impact
Highest effect
Typical dose:500–2000 EPA+DHA mg
The Omega-3s EPA and DHA are crucial for resolving inflammation throughout the body, which is a key factor in long-term health. They are integral components of brain cell membranes, supporting cognitive function, and also play a significant role in maintaining heart health and healthy blood lipid levels.

Study evidence

61 studies

Fish oil can lower triglycerides and may help selected health problems, but the supplied research does not show a consistent improvement in overall health or longevity. Results vary by population and formulation, with some trials finding no benefit or unfavorable outcomes.

View goal
Energy
Impact
High effect
Typical dose:500–2000 EPA+DHA mg
The omega-3 fatty acids EPA and DHA are integral components of mitochondrial membranes. Healthy membranes allow for more efficient energy production (ATP synthesis). Additionally, their anti-inflammatory properties can combat the low-grade inflammation that contributes to feelings of fatigue and malaise.

Study evidence

8 studies

Fish oil has not shown a consistent benefit for everyday energy or resistance to fatigue. Some improvements occur in particular medical populations, while exercise studies often show changes in oxygen use or metabolism without better endurance or performance.

View goal
Testosterone Support
Impact
High effect
Typical dose:500–2000 EPA+DHA mg
The health of cell membranes in the Leydig cells of the testes is critical for proper hormone production. Omega-3s improve membrane fluidity and function. Studies suggest that higher omega-3 intake is associated with improved testicular function and higher levels of Luteinizing Hormone (LH), a precursor signal for testosterone production.

Study evidence

3 studies

Fish oil is not established as a reliable testosterone booster. A favorable result in overweight and obese men contrasts with research showing no hormonal change, while observational links with reproductive health do not prove that fish oil raises testosterone.

View goal
Nail Health
Impact
Moderate effect
Typical dose:500–2000 EPA+DHA mg
The anti-inflammatory properties of Omega-3s support overall health, while the fats themselves can help lubricate and nourish the nail matrix. This can result in nails that are less dry and prone to splitting or peeling.

Study evidence

No published studies for this goal yet.

View goal
Showing 6 of 7 goals

Studies

Research connections will load here.
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular SupportWeight Loss
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support
  11. Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis.
    Pradelli L; Heller AR; Klek S; Mayer K; Rosenthal MD; Muscaritoli M · Nutrients · 2025
    Meta-analysis29 studies pooledGeneral Health
  12. Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial.
    Zhang C; Ge C; Wang J; Sun D · Food & nutrition research · 2022
    Randomized trial103 participantsGeneral HealthEnergy
  13. The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial.
    Guo XF; Wang C; Yang T; Ma WJ; Zhai J; Zhao T; Xu TC; Li J; Liu H; Sinclair AJ; Li D · European journal of nutrition · 2022
    Randomized trial111 participantsGeneral Health
  14. Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality.
    O'Keefe EL; O'Keefe JH; Tintle NL; Westra J; Albuisson L; Harris WS · Mayo Clinic proceedings · 2024
    Meta-analysis117,702 participants17 studies pooledGeneral Health
  15. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
    Marik PE; Varon J · Clinical cardiology · 2010
    Meta-analysis39,044 participants11 studies pooledGeneral Health
  16. Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females.
    Logan SL; Spriet LL · PloS one · 2016
    Randomized trial24 participantsEnergy
  17. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsEnergy
  18. DHA-rich Fish Oil Increases the Omega-3 Index and Lowers the Oxygen Cost of Physiologically Stressful Cycling in Trained Individuals.
    Hingley L; Macartney MJ; Brown MA; McLennan PL; Peoples GE · International journal of sport nutrition and exercise metabolism · 2018
    Randomized trial26 participantsEnergy
  19. Fish oil reduces heart rate and oxygen consumption during exercise.
    Peoples GE; McLennan PL; Howe PR; Groeller H · Journal of cardiovascular pharmacology · 2009
    Randomized trial16 participantsEnergy
  20. Dietary supplementation with docosahexaenoic acid rich fish oil increases circulating levels of testosterone in overweight and obese men.
    Abbott K; Burrows TL; Acharya S; Thota RN; Garg ML · Prostaglandins, leukotrienes, and essential fatty acids · 2021
    Randomized trial61 participantsTestosterone Support
  21. Fish oil produces an atherogenic lipid profile in hypertensive men.
    Hughes GS; Ringer TV; Watts KC; DeLoof MJ; Francom SF; Spillers CR · Atherosclerosis · 1991
    Randomized trial26 participantsTestosterone Support
  22. Associations of Fish Oil Supplement Use With Testicular Function in Young Men.
    Jensen TK; Priskorn L; Holmboe SA; Nassan FL; Andersson AM; Dalgård C; Petersen JH; Chavarro JE; Jørgensen N · JAMA network open · 2020
    Cross-sectional study1,679 participantsTestosterone Support
  23. Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: a randomized controlled trial.
    Yang B; Shi MQ; Li ZH; Shi L; Wang AM; Guo XJ; Li D · Food & function · 2019
    Randomized trial108 participantsWeight Loss
  24. Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis.
    Bender N; Portmann M; Heg Z; Hofmann K; Zwahlen M; Egger M · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2015
    Meta-analysisWeight Loss
  25. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.
    Kabir M; Skurnik G; Naour N; Pechtner V; Meugnier E; Rome S; Quignard-Boulangé A; Vidal H; Slama G; Clément K; Guerre-Millo M; Rizkalla SW · The American journal of clinical nutrition · 2008
    Randomized trial27 participantsWeight Loss
  26. Plasma ω-3 fatty acids in pregnancy are inversely associated with postpartum weight retention in a multiethnic Asian cohort.
    Loy SL; Ng MJH; Cheung YB; Godfrey KM; Calder PC; Lek N; Yap F; Müller-Riemenschneider F; Natarajan P; Chong YS; Tan KH; Shek LP; Chong MF; Chan JKY · The American journal of clinical nutrition · 2017
    Cohort study653 participantsWeight Loss